IGF1R and lung carcinoma: A study by Shali et al. [110] examined the co-delivery of insulin-like growth factor 1 receptor (IGF-1R)-specific small interfering RNA (siRNA) and DOX using chitosan-based NPs to improve anticancer efficacy in the A549 lung cancer cell line.